Yes, Evolysse is FDA-approved. Evolus launched its hyaluronic acid filler line in 2023 as a direct competitor to the Juvéderm and Restylane portfolios, with the product family now including multiple viscosity grades for different anatomical applications and depth of injection.
Injectables
Is Evolysse FDA Approved? Evolus's HA Filler Line Explained
Evolysse is FDA-approved and represents Evolus's entry into the hyaluronic acid filler market—here's how it compares to Juvéderm and Restylane.
1-YEAR MOVE
EOLS
▼15.6%
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| EOLS | Evolus | −15.6% |
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |